TIV mRNA-neuraminidase (NA)(Sanofi Pasteur)

N/A

Report date: 2025/03/13 20:00:06

Base Information

Drug NameTIV mRNA-neuraminidase (NA)(Sanofi Pasteur)

Drug Alias NameN/A

ClassificationVaccines > Development/production technology > Nucleic acid vaccine > RNA vaccineVaccines > Vaccine type > Multivalent vaccineVaccines > Application > Prophylactic vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsInfluenza, Human

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited StatesAustralia

CombinationsNo

Global Highest StatusPhase 2 Clinical

Highest Status in ChinaN/A

Originator CompaniesSanofi Pasteur

China Registration ClassN/A

Develop Information

Active CompaniesSanofi Pasteur

Inactive CompaniesN/A

Active IndicationsInfluenza, Human

Inactive IndicationsN/A

Other Information

ATC CodeN/A